Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart FailureAlexandre Mebazaa, for the SURVIVE Investigators, Markku S. Nieminen et al.|JAMA|2007Cited by 987
Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failureMaria Nikolaou, Alexandre Mebazaa, Sai͏̈d Laribi et al.|European Heart Journal|2012Cited by 316
Levosimendan: Molecular mechanisms and clinical implicationsZoltán Papp, Ferenc Folláth, István Édes et al.|International Journal of Cardiology|2011Cited by 313
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Journal of Cardiovascular Pharmacology|2020Cited by 111
The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinionMarkku S. Nieminen, Piero Pollesello, Michael Buerke et al.|International Journal of Cardiology|2016Cited by 83